FOXP3 and non-small cell lung carcinoma: The percentage of FoxP3 positive cells per all analyzed cells in neuroblastoma and ganglioneuroblastoma (indications with the highest numbers) was 0.4%, way below the 4.4% reported in a similar DIA in NSCLC 15.